Canon Medical Systems USA will unveil a new photon-counting CT (PCCT) scanner at RSNA 2026 in Chicago.
Ultimion, which is pending U.S. Food and Drug Administration (FDA) 510(k) clearance, combines photon-counting detector technology with AI-enabled image reconstruction to provide ultrahigh-resolution and spectral imaging from a single acquisition, according to the company. The system also includes INSTINX, Canon’s workflow software for integrating PCCT into clinical practice. Canon said Ultimion supports low-dose imaging and features air-cooled installation and PACS integration.
The firm noted it is also advancing AI-enabled image reconstruction across its CT portfolio in an effort to extend selected PCCT-inspired imaging benefits to conventional CT. To that end, at the premium end, for instance, Aquilion One/Insight Edition offers Precise IQ Engine (PIQE) deep-learning reconstruction technology along with motion compensation with Clear Motion.


















